Is Resveratrol worth it?
Resveratrol is the classic longevity-hype supplement: elegant cell and animal biology, weak human outcome proof. Oral resveratrol is heavily metabolized, and short human trials mostly chase biomarkers rather than heart attacks, strokes, or lifespan. For real cardiovascular health, this is not where the money should go.
The call
The strongest resveratrol story is mechanistic, not clinical. Human pharmacokinetic work shows oral resveratrol is absorbed but has very low parent-compound bioavailability because it is rapidly metabolized. In a Cochrane review of adults with type 2 diabetes, the available randomized trials were short, small, and did not report patient-relevant outcomes such as mortality, complications, quality of life, or treatment costs. Small human experiments can move surrogate blood-flow or metabolite measures, but that does not establish cardiovascular protection or human longevity benefit.
Safety
Resveratrol can cause gastrointestinal upset, nausea, diarrhea, loose stools, headache, and rash, especially at higher supplemental doses. Use caution with anticoagulants, antiplatelet drugs, NSAIDs, bleeding disorders, upcoming surgery, liver disease, kidney disease, hormone-sensitive conditions, fertility treatment, and cancer therapy because interaction and long-term safety data are incomplete. Avoid during pregnancy, breastfeeding, and childhood unless medically supervised. Be especially cautious with resveratrol plus piperine or other bioavailability enhancers because they may change drug exposure and make interactions harder to predict.
Dose that matters: No evidence-based cardio or longevity dose. Human trials use widely different short-term doses, including 10-1000 mg/day in metabolic studies, but no dose has shown reliable patient-relevant cardiovascular or lifespan benefit.
Sources
Tier 1 · evidence synthesis · Reviewed by the Stack-kit desk